M&A Deal Summary

Cantel Medical Acquires NAMSA - Sterility Assurance Monitoring Products Division

On February 3, 2016, Cantel Medical acquired medical products company NAMSA - Sterility Assurance Monitoring Products Division from NAMSA for 14M USD

Acquisition Highlights
  • This is Cantel Medical’s 8th transaction in the Medical Products sector.
  • This is Cantel Medical’s 12th largest (disclosed) transaction.
  • This is Cantel Medical’s 7th transaction in the United States.

M&A Deal Summary
Date 2016-02-03
Target NAMSA - Sterility Assurance Monitoring Products Division
Sector Medical Products
Buyer(s) Cantel Medical
Sellers(s) NAMSA
Deal Type Divestiture
Deal Value 14M USD

Target

NAMSA - Sterility Assurance Monitoring Products Division

United States
NAMSA - Sterility Assurance Monitoring Products Division is a manufacturer of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. Its domestic and international market segments include pharmaceutical, medical device, contract sterilizers, laboratories, health care, dental, food and beverage, and biotech companies.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cantel Medical

Little Falls, New Jersey, United States

website

Category Company
Founded 1963
Sector Medical Products
Revenue 1.0B USD (2020)
DESCRIPTION

Cantel Medical Corp. is a provider of medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Cantel Medical was formed in 1963 and is based in Little Falls, New Jersey.

DEAL STATS #
Overall 11 of 20
Sector (Medical Products) 8 of 15
Type (Divestiture) 2 of 5
Country (United States) 7 of 11
Year (2016) 1 of 3
Size (of disclosed) 12 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-14 Medical Innovations Group Holdings

Shoeburyness, United Kingdom

Medical Innovations Group Holdings Ltd. is a medical device company and is a provider of endoscope storage and transport systems in the UK and internationally.

Buy $80M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-01 Accutron

Windsor, Connecticut, United States

Accutron, Inc. is a manufacturer of nitrous oxide delivery systems and single-use nasal masks.

Buy $53M

Seller(S) 1

SELLER

NAMSA

Northwood, Ohio, United States

website

Category Company
Founded 1967
Sector Medical Products
DESCRIPTION

NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. NAMSA was established in 1967 and is based in Northwood, Ohio.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-07 Reimbursement Strategies

St. Paul, Minnesota, United States

Reimbursement Strategies LLC is a Minneapolis-based consultancy focused on reimbursement, health economics and market access for the international life science industry.

Buy -
Mergr

Product

Company

Legal